These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7535106)

  • 1. Analysis of multiple antigenic determinants of Clostridium perfringens enterotoxin as revealed by use of different synthetic peptides.
    Sugii S
    J Vet Med Sci; 1994 Dec; 56(6):1047-50. PubMed ID: 7535106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitope analysis of staphylococcal enterotoxin A using different synthetic peptides.
    Hu DL; Imai A; Ono K; Sasaki S; Nakane A; Sugii S; Shinagawa K
    J Vet Med Sci; 1998 Sep; 60(9):993-6. PubMed ID: 9795898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of multiple antigenic determinants of the bovine conglutinin molecule using different synthetic peptides.
    Sugii S
    J Vet Med Sci; 1994 Dec; 56(6):1035-40. PubMed ID: 7535105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A conjugated synthetic peptide corresponding to the C-terminal region of Clostridium perfringens type A enterotoxin elicits an enterotoxin-neutralizing antibody response in mice.
    Mietzner TA; Kokai-Kun JF; Hanna PC; McClane BA
    Infect Immun; 1992 Sep; 60(9):3947-51. PubMed ID: 1500207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping of functional regions of Clostridium perfringens type A enterotoxin.
    Hanna PC; Wieckowski EU; Mietzner TA; McClane BA
    Infect Immun; 1992 May; 60(5):2110-4. PubMed ID: 1373406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of a fusion protein carrying antigenic determinants of enteric clostridial toxins.
    Belyi IF; Varfolomeeva NA
    FEMS Microbiol Lett; 2003 Aug; 225(2):325-9. PubMed ID: 12951260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of the receptor-binding region of Clostridium perfringens enterotoxin utilizing cloned toxin fragments and synthetic peptides. The 30 C-terminal amino acids define a functional binding region.
    Hanna PC; Mietzner TA; Schoolnik GK; McClane BA
    J Biol Chem; 1991 Jun; 266(17):11037-43. PubMed ID: 1645721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innovative and Highly Sensitive Detection of
    Neumann T; Krüger M; Weisemann J; Mahrhold S; Stern D; Dorner MB; Feraudet-Tarisse C; Pöhlmann C; Schulz K; Messelhäußer U; Rimek D; Gessler F; Elßner T; Simon S; Rummel A; Dorner BG
    Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33917845
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of Adjuvant-Free Bivalent Food Poisoning Vaccine by Augmenting the Antigenicity of
    Suzuki H; Hosomi K; Nasu A; Kondoh M; Kunisawa J
    Front Immunol; 2018; 9():2320. PubMed ID: 30356722
    [No Abstract]   [Full Text] [Related]  

  • 10. In silico design of a novel chimeric shigella IpaB fused to C terminal of clostridium perfringens enterotoxin as a vaccine candidate.
    Arabshahi S; Nayeri Fasaei B; Derakhshandeh A; Novinrooz A
    Bioengineered; 2018 Jan; 9(1):170-177. PubMed ID: 29091543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a bivalent food poisoning vaccine: augmented antigenicity of the C-terminus of Clostridium perfringens enterotoxin by fusion with the B subunit of Escherichia coli Shiga toxin 2.
    Hosomi K; Hinenoya A; Suzuki H; Nagatake T; Nishino T; Tojima Y; Hirata SI; Matsunaga A; Kondoh M; Yamasaki S; Kunisawa J
    Int Immunol; 2019 Feb; 31(2):91-100. PubMed ID: 30329068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of enzyme linked immunosorbent assay (ELISA) in the quantitation of Clostridium perfringens type A enterotoxin and antienterotoxin antibodies.
    Narayan KG; Genigeorgis C; Behymer D
    Int J Zoonoses; 1983 Dec; 10(2):105-10. PubMed ID: 6327556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric analysis for enterotoxin exposed on Clostridium perfringens spores.
    Kusunoki H; Hu D; Piyankarage RH; Sugii S; Uemura T
    J Vet Med Sci; 1998 Dec; 60(12):1357-9. PubMed ID: 9879540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of Clostridium perfringens enterotoxin.
    McClane BA
    Toxicon; 1996; 34(11-12):1335-43. PubMed ID: 9027990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenicity of amino-acid sequences from Clostridium difficile toxin B.
    Torres JF; Monath TP
    J Med Microbiol; 1996 Jun; 44(6):464-74. PubMed ID: 8636964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety of a mucosal vaccine using the C-terminal fragment of Clostridium perfringens enterotoxin.
    Suzuki H; Kakutani H; Kondoh M; Watari A; Yagi K
    Pharmazie; 2010 Oct; 65(10):766-9. PubMed ID: 21105580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clostridium perfringens enterotoxin-based protein engineering for the vaccine design and delivery system.
    Lan H; Hosomi K; Kunisawa J
    Vaccine; 2019 Sep; 37(42):6232-6239. PubMed ID: 31466706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular determinants of the interaction between Clostridium perfringens enterotoxin fragments and claudin-3.
    Winkler L; Gehring C; Wenzel A; Müller SL; Piehl C; Krause G; Blasig IE; Piontek J
    J Biol Chem; 2009 Jul; 284(28):18863-72. PubMed ID: 19429681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A synthetic peptide corresponding to the extracellular loop 2 region of claudin-4 protects against Clostridium perfringens enterotoxin in vitro and in vivo.
    Shrestha A; Robertson SL; Garcia J; Beingasser J; McClane BA; Uzal FA
    Infect Immun; 2014 Nov; 82(11):4778-88. PubMed ID: 25156725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction of Clostridium perfringens enterotoxin with receptor claudins.
    Shrestha A; Uzal FA; McClane BA
    Anaerobe; 2016 Oct; 41():18-26. PubMed ID: 27090847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.